Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
02/2002
02/27/2002EP0932689B1 Assays for homocysteine and homocysteine desulphurase from protozoan trichomonasvaginalis
02/27/2002EP0858509B1 Dna sequences encoding cmh-1, a cysteine protease involved in apoptosis
02/27/2002EP0840792B1 (s)-hydroxynitrillyase from hevea brasiliensis
02/27/2002EP0733114B1 Construction of pasteurella haemolytica mutants
02/27/2002EP0536330B1 Glyphosate tolerant plants
02/27/2002CN1338002A Polysaccharides containing alpha-1,4-glucan chains and method for producing same
02/27/2002CN1337999A Recovery of a protein at high pH
02/27/2002CN1337998A Multi-enzyme product comprising glucoumylolytic, proteolytic and xylanolytic activities and process for preparing the same
02/27/2002CN1337465A Gene sequency of specific dihydro-flavonol4-reducing enayme as code substrate and its use thereof
02/27/2002CN1079831C Gene encoding carboxypeptidase of aspergillus niger
02/26/2002US6350934 Nucleic acid encoding delta-9 desaturase
02/26/2002US6350866 A nucleic acid encoding a protein; for developing and screening drugs that bind and inhibit the protein; therapy for respiratory diseases
02/26/2002US6350856 Cytokine suppressive anti-inflammatory drug binding protein
02/26/2002US6350728 Coated enzyme preparation with an improved solubility
02/26/2002US6350604 Alkaline lipolytic enzyme
02/26/2002US6350603 Phosphodiesterase 10
02/26/2002US6350602 Purified and isolated dna molecule which encodes a fungal phytase which catalyzes the liberation of inorganic phosphorus from myoinositol hexakis-phosphate
02/26/2002US6350600 A polypeptide encoding transfer rna-methyl transferase; screening antibiotics, therapy for streptococcus pneumoniae infections; drug development
02/26/2002US6350599 A modified amino acid sequence of a pullulanse that has improved properties as; altered ph dependent activity and/or altered substrate specificity, increase specific activity, an altered cleavage pattern, and improved thermostability
02/26/2002US6350598 MurD
02/26/2002US6350597 An isolated nucleic acid; development of herbicides, fungicides and antibiotics
02/26/2002US6350591 A dna containing a fragment from thermus flavus, containing an insertion site for an exogenous dna, and also controls the targeted insert into a region of a thermus chromosome, so that the heterologous thermostable proteins are expressed
02/26/2002US6350448 Human prostate-associated protease
02/26/2002US6350447 Polypeptides with amino acid sequences and proteins
02/26/2002US6350446 Polypeptides with amino acid sequences for kidney failure
02/26/2002CA2159724C Selecting genes encoding catalytic antibodies
02/26/2002CA2131775C Process for producing trans-4-hydroxy-l-proline
02/26/2002CA2079454C Steroid 5.alpha.-reductases
02/26/2002CA2038030C Synthetic peptides which contain sequences from factor viia, and the use thereof
02/26/2002CA2024672C Indole, benzofuran,and benzothiophene containing lipoxygenase inhibiting compounds
02/21/2002WO2002014595A1 A method for treating proteinaceous fibres
02/21/2002WO2002014543A2 Process for detecting enzyme activity in an immunoassay
02/21/2002WO2002014542A2 Process for detecting serine/threonine kinase activity
02/21/2002WO2002014522A1 Pyruvate:nadp+ oxidoreductase and uses thereof
02/21/2002WO2002014518A1 Method of modifying microorganism-origin transglutaminase
02/21/2002WO2002014512A1 Novel proteins and dnas thereof
02/21/2002WO2002014502A2 Sclerotinia-inducible genes and promoters and their uses
02/21/2002WO2002014497A2 Genes encoding mutant p-coumarate 3-hydroxylase (c3h) and methods of use
02/21/2002WO2002014494A2 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed
02/21/2002WO2002014485A2 Kallikrein gene
02/21/2002WO2002014484A1 A tyrosinase enzyme
02/21/2002WO2002014483A2 Human adenosine deaminase
02/21/2002WO2002014482A2 Polyketides and their synthesis
02/21/2002WO2002014478A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY
02/21/2002WO2002014468A2 Phage-dependent superproduction of biologically active protein and peptides
02/21/2002WO2002014355A2 Novel mitogen activated kinase
02/21/2002WO2002014349A2 Non-covalent inhibitors of urokinase and blood vessel formation
02/21/2002WO2002013763A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
02/21/2002WO2002013609A1 METHODS FOR BLOCKING RESISTANCE TO Bt TOXINS IN INSECTS AND NEMATODES
02/21/2002WO2002013602A1 Transgenic non-human mammal and method of constructing the same, animal disease model and method of clarifying gene function
02/21/2002WO2001088084A3 A novel polypeptide, a superoxide dismutase 11 and the polynucleotide encoding the polypeptide
02/21/2002WO2001083722A3 Enzymes useful for treating and methods for treating mps-vi and cells lines for producing such enzymes recombinantly
02/21/2002WO2001079443A3 Albumin fusion proteins
02/21/2002WO2001079430A3 A novel polypeptide - human serine protease 9 and the polynucleotide encoding said polypeptide
02/21/2002WO2001077336A3 Acyl-coa dehydrogenase mutant and uses thereof
02/21/2002WO2001075037A3 A new polypeptide- human dihydroorotase 40 and the polynucleotide encoding it
02/21/2002WO2001075032A3 A novel polypeptide, human glycinamide ribonucleotide synthetase 10 and the polynucleotide encoding the polypeptide
02/21/2002WO2001075027A3 A new polypeptide-human rna helicase 13 and the polynucleotide encoding it
02/21/2002WO2001075005A3 A novel polypeptide, sub-unit c of vacuolar proton-pumping atpase (v-atpase) 12 and the polynucleotide encoding the polypeptide
02/21/2002WO2001072977A3 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
02/21/2002WO2001066768A8 Dna molecule coding for a polygalacturonase of strawberry and the uses thereof
02/21/2002WO2001066704A3 Methods for making plants tolerant to glyphosate and compositions thereof
02/21/2002WO2001064910A3 Atpase-like molecule and uses thereof
02/21/2002WO2001064895A3 27411, a human phosphatidyl-glycerolphosphate (pgp) synthase
02/21/2002WO2001058276A3 Use of acid-stable proteases in animal feed
02/21/2002WO2001058275A3 Use of acid-stable subtilisin proteases in animal feed
02/21/2002WO2001055319A3 Endocrine related nucleic acids, proteins and antibodies
02/21/2002WO2001051629A3 Circularly permutated, interaction-activated proteins
02/21/2002WO2001049832A3 Transduction of recombinases for inducible gene targeting
02/21/2002WO2001046397A3 Human kinases
02/21/2002WO2001038501A3 Human serine protease
02/21/2002WO2001029242A3 Post-translational modification of recombinant proteins produced in plants
02/21/2002WO2001023586A3 Transacylases of the paclitaxel biosynthetic pathway
02/21/2002US20020023279 Forages
02/21/2002US20020023276 Expression vectors for use in food processing; for use in the detction of cancer; for use in pre venting milk spoilage
02/21/2002US20020023275 Transgenic mice containing matrix metalloprotease gene disruptions
02/21/2002US20020022947 Simulator, method and recording medium for simulating a biological system
02/21/2002US20020022258 Nucleotide sequences that codes enzymatic polypeptide; for use in the generation of disease resistant plants
02/21/2002US20020022256 Polypeptide; for use in the generation of disease resistant plants
02/21/2002US20020022255 Expresson vectors; for use as tool in genetic engineering and gene therapy
02/21/2002US20020022254 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
02/21/2002US20020022249 Nucleotide sequences which code enzymatic polypeptide; for use in the diagnosis and treatment of cancer and blood disorders
02/21/2002US20020022248 Compositions and methods for the therapy and diagnosis of prostate cancer
02/21/2002US20020022242 Detection of preferential nervous system disorder; obtain sample of body fluid, detect preferential enzyme with adjusted glycosylation pattern
02/21/2002US20020022239 Fluorescent adducts comprising an apoprotein and a bilin (e.g. apophytochrome-phycoerythrobilin adducts); intensely fluorescent, photostable proteins useful as probes for biological research
02/21/2002US20020022051 For burns, injuries of skin; lyases enzyme on carrier
02/21/2002US20020022023 Treatment of diabetes mellitus and insulin receptor signal transduction
02/21/2002US20020020668 Applied to enzymes during protein purification; antifouling agents
02/21/2002DE10109689A1 Neue für das metE-Gen kodierende Nukleotidsequenzen New coding for the metE gene nucleotide sequences
02/21/2002DE10109687A1 Neue für das metH-Gen kodierende Nukleotidsequenzen New coding for the metH gene nucleotide sequences
02/21/2002DE10109686A1 Neue für das metf-Gen kodierende Nukleotidsequenzen New coding for the metF gene nucleotide sequences
02/21/2002DE10036753A1 New amylolytic enzyme from Bacillus, useful e.g. in cleaning compositions and for starch liquefaction
02/21/2002DE10036752A1 New amylolytic enzyme from Bacillus, useful e.g. in cleaning compositions and for starch liquefaction
02/21/2002CA2420037A1 Immunogenic hbc chimer particles having enhanced stability
02/21/2002CA2419538A1 Polyketides and their synthesis
02/21/2002CA2419524A1 Genes encoding mutant p-coumarate 3-hydroxylase (c3h) and methods of use
02/21/2002CA2419505A1 Use of a transgene encoding a vertebrate phytase to increase capacity to utilize phytic acid in livestock feed
02/21/2002CA2419203A1 Phage-dependent superproduction of biologically active protein and peptides
02/21/2002CA2419020A1 Pyruvate:nadp+ oxidoreductase and uses thereof
02/21/2002CA2418365A1 Methods for blocking resistance to bt toxins in insects and nematodes